The instant disclosure features, among other things, compositions and methods for treating an autism spectrum disorder in a human. The compositions comprise an effective amount of: (1) an isothiocyanate (e.g., sulforaphane or a derivative thereof) or (2) a glucosinolate, and optionally, an enzyme, to thereby treat an autism spectrum disorder and/or reduce the severity of at least one symptom of the disorder. Methods for preparing such compositions are also featured.
本公开的内容包括用于治疗人类自闭症谱系障碍的组合物和方法。这些组合物包含有效量的(1) 异
硫氰酸酯(例如,
莱菔硫烷或其衍
生物)或 (2)
葡萄糖苷酸盐,以及可选的酶,从而治疗自闭症谱系障碍和/或降低该障碍至少一种症状的严重程度。此外,还介绍了制备此类组合物的方法。